 | • レポートコード：C-GIR014957 • 出版社/出版日：GlobalInfoResearch / 2018年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール • 産業分類：医療・バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートでは、パーキンソン病の治療の世界市場について調査・分析し、パーキンソン病の治療の世界市場概観、メーカー動向、メーカー別パーキンソン病の治療シェア、市場規模推移、市場規模予測、パーキンソン病の治療種類別分析（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作用薬）、パーキンソン病の治療用途別分析（病院、診療所）、主要地域分析（北米、欧州、アジア）、主要国分析データなどを含め、以下の構成でお届け致します。 ・パーキンソン病の治療の市場概観 ・パーキンソン病の治療のメーカー概要（事業概要、製品種類、価格、売上、市場シェア等） ・パーキンソン病の治療のメーカー別販売動向、市場シェア、市場集中度、競争動向 ・パーキンソン病の治療の世界市場規模 ・パーキンソン病の治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・パーキンソン病の治療のアメリカ市場規模推移 ・パーキンソン病の治療のカナダ市場規模推移 ・パーキンソン病の治療のメキシコ市場規模推移 ・パーキンソン病の治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・パーキンソン病の治療のドイツ市場規模推移 ・パーキンソン病の治療のイギリス市場規模推移 ・パーキンソン病の治療のロシア市場規模推移 ・パーキンソン病の治療のアジア市場分析（日本、中国、韓国、インド、東南アジア等） ・パーキンソン病の治療の日本市場規模推移 ・パーキンソン病の治療の中国市場規模推移 ・パーキンソン病の治療の韓国市場規模推移 ・パーキンソン病の治療のインド市場規模推移 ・パーキンソン病の治療の東南アジア市場規模推移 ・パーキンソン病の治療の南米・中東・アフリカ市場分析 ・パーキンソン病の治療の種類別分析/市場規模推移（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作用薬） ・パーキンソン病の治療の用途別分析/市場規模推移（病院、診療所） ・パーキンソン病の治療の市場予測（地域別予測、種類別予測、用途別予測） ・パーキンソン病の治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Parkinson’s disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Scope of the Report:
This report studies the Parkinson’s Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Parkinson’s Disease Treatment market by product type and applications/end industries.
There is no cure for Parkinson’s disease, with treatment directed at improving symptoms. Initial treatment is typically with the antiparkinson medication levodopa (L-DOPA), with dopamine agonistsbeing used once levodopa becomes less effective. As the disease progresses and neurons continue to be lost, these medications become less effective while at the same time they produce a complication marked by involuntary writhing movements. Diet and some forms of rehabilitation have shown some effectiveness at improving symptoms.
The global Parkinson’s Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Parkinson’s Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
GSK
Merck
Novartis
Teva
Boehringer Ingelheim
Impax
Abbvie
Bausch Health
Lundbeck
Sun Pharmaceutical Industries
Wockhardt
Acadia Pharmaceuticals
UCB
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Levodopa/carbidopa
Dopamine Receptor Agonists
MAO-Inhibitors
COMT-inhibitors
Anticholinergics
Market Segment by Applications, can be divided into
Hospitals
Clinics
レポート目次Table of Contents
1 Parkinson’s Disease Treatment Market Overview
1.1 Product Overview and Scope of Parkinson’s Disease Treatment
1.2 Classification of Parkinson’s Disease Treatment by Types
1.2.1 Global Parkinson’s Disease Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Parkinson’s Disease Treatment Revenue Market Share by Types in 2017
1.2.3 Levodopa/carbidopa
1.2.4 Dopamine Receptor Agonists
1.2.5 MAO-Inhibitors
1.2.6 COMT-inhibitors
1.2.7 Anticholinergics
1.3 Global Parkinson’s Disease Treatment Market by Application
1.3.1 Global Parkinson’s Disease Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Parkinson’s Disease Treatment Market by Regions
1.4.1 Global Parkinson’s Disease Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Parkinson’s Disease Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Parkinson’s Disease Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson’s Disease Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Parkinson’s Disease Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson’s Disease Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Parkinson’s Disease Treatment (2013-2023)
2 Manufacturers Profiles
2.1 GSK
2.1.1 Business Overview
2.1.2 Parkinson’s Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Parkinson’s Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Parkinson’s Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva
2.4.1 Business Overview
2.4.2 Parkinson’s Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Parkinson’s Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Impax
2.6.1 Business Overview
2.6.2 Parkinson’s Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Impax Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbvie
2.7.1 Business Overview
2.7.2 Parkinson’s Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbvie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bausch Health
2.8.1 Business Overview
2.8.2 Parkinson’s Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bausch Health Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Lundbeck
2.9.1 Business Overview
2.9.2 Parkinson’s Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Lundbeck Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharmaceutical Industries
2.10.1 Business Overview
2.10.2 Parkinson’s Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharmaceutical Industries Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.11 Wockhardt
2.11.1 Business Overview
2.11.2 Parkinson’s Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Wockhardt Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.12 Acadia Pharmaceuticals
2.12.1 Business Overview
2.12.2 Parkinson’s Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Acadia Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.13 UCB
2.13.1 Business Overview
2.13.2 Parkinson’s Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parkinson’s Disease Treatment Market Competition, by Players
3.1 Global Parkinson’s Disease Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson’s Disease Treatment Players Market Share
3.2.2 Top 10 Parkinson’s Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Parkinson’s Disease Treatment Market Size by Regions
4.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Regions
4.2 North America Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
5 North America Parkinson’s Disease Treatment Revenue by Countries
5.1 North America Parkinson’s Disease Treatment Revenue by Countries (2013-2018)
5.2 USA Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
6 Europe Parkinson’s Disease Treatment Revenue by Countries
6.1 Europe Parkinson’s Disease Treatment Revenue by Countries (2013-2018)
6.2 Germany Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.4 France Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries
7.1 Asia-Pacific Parkinson’s Disease Treatment Revenue by Countries (2013-2018)
7.2 China Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.5 India Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
8 South America Parkinson’s Disease Treatment Revenue by Countries
8.1 South America Parkinson’s Disease Treatment Revenue by Countries (2013-2018)
8.2 Brazil Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Parkinson’s Disease Treatment by Countries
9.1 Middle East and Africa Parkinson’s Disease Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Parkinson’s Disease Treatment Revenue and Growth Rate (2013-2018)
10 Global Parkinson’s Disease Treatment Market Segment by Type
10.1 Global Parkinson’s Disease Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Parkinson’s Disease Treatment Market Forecast by Type (2018-2023)
10.3 Levodopa/carbidopa Revenue Growth Rate (2013-2023)
10.4 Dopamine Receptor Agonists Revenue Growth Rate (2013-2023)
10.5 MAO-Inhibitors Revenue Growth Rate (2013-2023)
10.6 COMT-inhibitors Revenue Growth Rate (2013-2023)
10.7 Anticholinergics Revenue Growth Rate (2013-2023)
11 Global Parkinson’s Disease Treatment Market Segment by Application
11.1 Global Parkinson’s Disease Treatment Revenue Market Share by Application (2013-2018)
11.2 Parkinson’s Disease Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
12 Global Parkinson’s Disease Treatment Market Size Forecast (2018-2023)
12.1 Global Parkinson’s Disease Treatment Market Size Forecast (2018-2023)
12.2 Global Parkinson’s Disease Treatment Market Forecast by Regions (2018-2023)
12.3 North America Parkinson’s Disease Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Parkinson’s Disease Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Parkinson’s Disease Treatment Revenue Market Forecast (2018-2023)
12.6 South America Parkinson’s Disease Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Parkinson’s Disease Treatment Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and FiguresFigure Parkinson's Disease Treatment Picture
Table Product Specifications of Parkinson's Disease Treatment
Table Global Parkinson's Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Parkinson's Disease Treatment Revenue Market Share by Types in 2017
Figure Levodopa/carbidopa Picture
Figure Dopamine Receptor Agonists Picture
Figure MAO-Inhibitors Picture
Figure COMT-inhibitors Picture
Figure Anticholinergics Picture
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Application (2013-2023)
Figure Parkinson's Disease Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Table Global Market Parkinson's Disease Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Parkinson's Disease Treatment Type and Applications
Table GSK Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Parkinson's Disease Treatment Type and Applications
Table Merck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Parkinson's Disease Treatment Type and Applications
Table Novartis Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Parkinson's Disease Treatment Type and Applications
Table Teva Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Parkinson's Disease Treatment Type and Applications
Table Boehringer Ingelheim Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Impax Basic Information, Manufacturing Base and Competitors
Table Impax Parkinson's Disease Treatment Type and Applications
Table Impax Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Parkinson's Disease Treatment Type and Applications
Table Abbvie Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Parkinson's Disease Treatment Type and Applications
Table Bausch Health Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Lundbeck Basic Information, Manufacturing Base and Competitors
Table Lundbeck Parkinson's Disease Treatment Type and Applications
Table Lundbeck Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Industries Parkinson's Disease Treatment Type and Applications
Table Sun Pharmaceutical Industries Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Parkinson's Disease Treatment Type and Applications
Table Wockhardt Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Acadia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Acadia Pharmaceuticals Parkinson's Disease Treatment Type and Applications
Table Acadia Pharmaceuticals Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Parkinson's Disease Treatment Type and Applications
Table UCB Parkinson's Disease Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Players (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Players in 2016
Figure Global Parkinson's Disease Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Parkinson's Disease Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Parkinson's Disease Treatment Revenue Market Share in 2017
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Market Share by Regions in 2017
Figure North America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure South America Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table North America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
Table North America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure USA Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Europe Parkinson's Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure Germany Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure UK Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure France Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Parkinson's Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure China Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure India Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table South America Parkinson's Disease Treatment Revenue by Countries (2013-2018)
Table South America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure Brazil Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Parkinson's Disease Treatment Revenue and Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Type (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Type (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Type in 2017
Table Global Parkinson's Disease Treatment Revenue Forecast by Type (2018-2023)
Figure Global Parkinson's Disease Treatment Market Share Forecast by Type (2018-2023)
Figure Global Levodopa/carbidopa Revenue Growth Rate (2013-2018)
Figure Global Dopamine Receptor Agonists Revenue Growth Rate (2013-2018)
Figure Global MAO-Inhibitors Revenue Growth Rate (2013-2018)
Figure Global COMT-inhibitors Revenue Growth Rate (2013-2018)
Figure Global Anticholinergics Revenue Growth Rate (2013-2018)
Table Global Parkinson's Disease Treatment Revenue by Application (2013-2018)
Table Global Parkinson's Disease Treatment Revenue Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Application (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue Share by Application in 2017
Table Global Parkinson's Disease Treatment Revenue Forecast by Application (2018-2023)
Figure Global Parkinson's Disease Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Parkinson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Parkinson's Disease Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Parkinson's Disease Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure Europe Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure South America Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Parkinson's Disease Treatment Revenue Market Forecast (2018-2023)